Innovative treatments: waiting times vary across European countries

Access times to innovative treatments vary significantly across European countries, with some patients waiting several months.

Published 11sem1 sourceNotableupdated 5h

≈ 20sSpeed

The fact

This disparity reflects differences in healthcare systems and drug approval processes.

Inequalities in access to modern therapies remain a major issue for the European Union.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on May 21, 2026